Psyence Biomedical (PBM) Free Cash Flow (2023)
Psyence Biomedical (PBM) recorded quarterly Free Cash Flow of -$1.6 million in Q1 2023.
Psyence Biomedical (PBM) Free Cash Flow (2023) Analysis & Trends
Psyence Biomedical's Free Cash Flow history runs 1 years deep, the most recent figure standing at -$1.6 million for Q1 2023.
- In Q1 2023, Free Cash Flow changed N/A year-over-year to -$1.6 million; the TTM figure through Mar 2025 stood at -$1.6 million (changed N/A YoY), while the FY2025 annual figure was -$9877.0, up 99.66% from the prior year.
- Free Cash Flow was -$1.6 million for Q1 2023 at Psyence Biomedical.
- In the past five years, Free Cash Flow ranged from a high of -$1.6 million in Q1 2023 to a low of -$1.6 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 848.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1.59 Mn |
| Mar 31, 2023 | -1.59 Mn |